SuperGen, Inc. (NASDAQ: SUPG) is focused on building a global, sustainable business by developing and commercializing new drug candidates for oncologists, hematologists, and their patients. The company’s staff is made up of talented individuals who recognize the incredible challenges of drug development. Although some work along and other on teams, each employee brings a distinct perspective to his or her job and is focused on the goal of bringing better products to cancer patients in need. For further information, visit the Company’s web site at www.sunesis.com.
- 17 years ago
QualityStocks
SuperGen, Inc. (NASDAQ: SUPG)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Powering AI: Nicola Mining Inc.’s (TSX.V: NIM) (OTCQB: HUSIF) Copper Project Aligns with Data Center Surge
As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth has become…
-
Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Breaks Ground on REE Processing Facility, Pioneers Domestic Supply Chain
The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. The…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
The new FDA voucher program aims to speed approval of drugs aligned with national health…